Characterization of the coupled plasma filtration–adsorption resin cartridge adsorptive capacity for cytokines and inflammatory mediators: adsorption profiles from septic patient plasma and in vitro endotoxin-stimulated whole blood

Livigni, Sergio; Silengo, Daniela; Maio, Mariella; Perlo, V; Pozzato, Marco; Selvaggi, Paola; Sereni, Luisa; Wratten, Mary Lou

doi:10.1186/cc5278

Search citation statements

Order By: Relevance

Paper Sections

Select...

Coupled Plasma Filtration and Adsorption (Cpfa)1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…20 A small randomized trial by Hu et al 21 in 14 patients showed that CPFA could be superior to high volume hemofiltration (HVHF) in improving the clinical manifestations and eliminating inflammatory mediators.…”

Section: Coupled Plasma Filtration and Adsorption (Cpfa)mentioning

confidence: 99%

Recent Advances in Extracorporeal Therapies

Shah

2013

Apollo Medicine

View full text Add to dashboard Cite

Polymyxin BHigh cut off (HCO) membranes Cytokine binding therapies a b s t r a c t Continuous renal replacement therapies (CRRT) started as continuous arterio-venous hemodialysis (CAVH) 2 in the 1970s. Since then, the last 4 decades have seen numerous improvements in extracorporeal therapies. Some of the notable improvements have been the development of veno-venous therapies, the development of special low resistance filters with special geometry and fibers and improved machine safety with the use of microprocessors and sensors.Classic extracorporeal therapies have focused on the removal of small solutes for efficacy. However, it is well known that the characteristics of some solutes make their removal difficult. Also, limitations in efficiency of dialysis membranes, advances in hemadsorption and the development of newer filters have led to the application of extracorporeal therapies in the management of patients with multi-organ failure and sepsis, refractory congestive heart failure, acute neurologic injury, liver failure and patients with various other ailments.

show abstract

Section: Coupled Plasma Filtration and Adsorption (Cpfa)mentioning

confidence: 99%

Recent Advances in Extracorporeal Therapies

Shah

2013

Apollo Medicine

View full text Add to dashboard Cite

show abstract

Characterization of the coupled plasma filtration–adsorption resin cartridge adsorptive capacity for cytokines and inflammatory mediators: adsorption profiles from septic patient plasma and in vitro endotoxin-stimulated whole blood

Cited by 1 publication

References 0 publications

Recent Advances in Extracorporeal Therapies

Recent Advances in Extracorporeal Therapies

Contact Info

Product

Resources

About